About the Company Our client is the premier distributor of medical devices in Thailand. With a commitment... to excellence and innovation, they provide top-tier solutions to medical professionals across the region, ensuring optimal patient...
Danone Specialized Nutrition Thailand is seeking for Senior Medical Brand Manager. With our global presence, brands... performance analysis, HCPs research & insight, mom journey in medical channel, communication and activities tracking, market...
Top dividend yield stocks: Coal India and Gujarat State Fertilisers & Chemicals are on Religare Broking's list of top 10 dividend yield stocks. Continue Reading »
Budget 2024: Hemal Shah of Torus ORO PMS has suggested L&T, HDFC Bank, Canfin Homes, and Oil India ahead of the upcoming Union Budget saying that the stocks can benefit most out of the policy announcements. Continue Reading »
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »